G Dranitsaris: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs

George Dranitsaris, Ilse Truter, Martie S. Lubbe, Wayne Cottrell, Biljana Spirovski, Jonathan Edwards

Journal:

Journal of Evaluation in Clinical Practice

Year:

2012

Language:

english

File:

PDF, 258 KB

english, 2012

2

Biosimilars of Biological Drug Therapies

Dr George Dranitsaris, Eitan Amir, Kristine Dorward

Journal:

Year:

2011

Language:

english

File:

PDF, 144 KB

english, 2011

3

Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?

Sonpavde, Guru, Dranitsaris, George, Necchi, Andrea

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 130 KB

english, 2018

4

The development of a value based pricing index for new drugs in metastatic colorectal cancer

George Dranitsaris, Ilse Truter, Martie S. Lubbe

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 157 KB

english, 2011

5

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris, George, Jacobs, Ira, Kirchhoff, Carol, Popovian, Robert, Shane, Lesley G

Journal:

ClinicoEconomics and Outcomes Research

Year:

2017

Language:

english

File:

PDF, 250 KB

english, 2017

6

Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness

Dranitsaris, George, Shane, Lesley G, Woodruff, Seth

Journal:

Journal of Oncology Pharmacy Practice

Year:

2017

Language:

english

File:

PDF, 193 KB

english, 2017

7

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

Farrah Kassam, Katherine Enright, Rebecca Dent, George Dranitsaris, Jeff Myers, Candi Flynn, Michael Fralick, Ritu Kumar, Mark Clemons

Journal:

Clinical Breast Cancer

Year:

2009

Language:

english

File:

PDF, 117 KB

english, 2009

8

A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy

Chiarotto, James A, Akbarali, Riyad, Bellotti, Lara, Dranitsaris, George

Journal:

Cancer Management and Research

Year:

2017

Language:

english

File:

PDF, 484 KB

english, 2017

9

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death

Eileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, Michelle Ezer, Sunil Verma, George Dranitsaris, Mark Clemons

Journal:

Breast Cancer Research and Treatment

Year:

2005

Language:

english

File:

PDF, 188 KB

english, 2005

10

Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications

Hatzimichael, Eleftheria, Dasoula, Aggeliki, Kounnis, Valentinos, Benetatos, Leonidas, Nigro, Cristiana Lo, Lattanzio, Laura, Papoudou-Bai, Alexandra, Dranitsaris, George, Briasoulis, Evangelos, Crook

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 228 KB

english, 2012

11

Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost

Dranitsaris, George, Ellis, Anne K.

Journal:

Journal of Evaluation in Clinical Practice

Year:

2014

Language:

english

File:

PDF, 320 KB

english, 2014

12

FOLFOX chemotherapy can safely be given to neutropenic patients with early-stage colorectal cancer for higher dose intensity and fewer visits

Chiarotto, James A., Dranitsaris, George

Journal:

Supportive Care in Cancer

Year:

2016

Language:

english

File:

PDF, 386 KB

english, 2016

13

The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant

Aaron D. Schimmer, George Dranitsaris, Val Ali, Margaret Falconer, Armand Keating

Journal:

Supportive Care in Cancer

Year:

2002

Language:

english

File:

PDF, 47 KB

english, 2002

14

Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC): A Systematic Review and Indirect Comparison of Safety and Efficacy

Dranitsaris, G., Schmitz, S., Broom, R.J.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 60 KB

english, 2013

15

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost

Dranitsaris, George, Ellis, Anne K

Journal:

Allergy, Asthma & Clinical Immunology

Year:

2014

Language:

english

File:

PDF, 70 KB

english, 2014

16

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

Dranitsaris, G., Vincent, M. D., Yu, J., Huang, L., Fang, F., Lacouture, M. E.

Journal:

Annals of Oncology

Year:

2012

Language:

english

File:

PDF, 122 KB

english, 2012

17

A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer

Adunlin, G, Diaby, V, Campbell, ES, Xiao, H, Montero, AJ, Dranitsaris, G

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 91 KB

english, 2016

18

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients

George Dranitsaris, Eleftheria Hatzimichael

Journal:

Supportive Care in Cancer

Year:

2012

Language:

english

File:

PDF, 164 KB

english, 2012

19

0136 The number needed to treat to save a life: A comparison between aromatase inhibitors

H.S. Rugo, G. Dranitsaris, S. Kaura

Journal:

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

20

The price function of toxicity

Mark D Vincent, George Dranitsaris

Journal:

The Lancet Oncology

Year:

2009

Language:

english

File:

PDF, 212 KB

english, 2009

21

PRS39 THE IMPACT OF FORMULARY POLICIES ON THE USE OF MEDICATION FOR RESPIRATORY DISEASE: A COMPARISON OF DRUG UTILIZATION IN THE PROVINCES OF ONTARIO AND ALBERTA

J Pilla, L Dunn, G Dranitsaris

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 68 KB

english, 2008

22

PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCER

G. Dranitsaris, I. Truter, M. Lubbe

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

23

PNP20: COST UTILITY ANALYSIS OF IMMUNOGLOBULINS (IVIG) VERSUS PLASMA EXCHANGE (PE) FOR THE TREATMENT OF GUILLAIN BARRE SYNDROME (GBS)

F Jivraj, G Dranitsaris, M Nicolle

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

24

Eltrombopag or Intravenous Immunoglobulin as a Bridge to Splenectomy in Adults With Chronic Idiopathic Thrombocytopenic Purpura: A Canadian Economic Analysis

George Dranitsaris, Peter Tsang

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

25

MOTHS AS PESTS IN THE PHARMACY.

Dranitsaris, G., Schmitz, S., Broom, R.J.

Journal:

Year:

1921

Language:

english

File:

PDF, 416 KB

english, 1921

26

Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd): A Rare Events Meta Analysis Of Clinically Relevant Adverse Events

Dranitsaris, G., Schmitz, S., Adunlin, G., Lindner, L., Rea, R.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

27

Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer

Dranitsaris, George, Cottrell, Wayne, Evans, William K.

Journal:

Current Opinion in Oncology

Year:

2002

Language:

english

File:

PDF, 426 KB

english, 2002

28

Estimating the Cost of Illness in Colorectal Cancer Patients Who Were Hospitalized for Severe Chemotherapy-Induced Diarrhea

Dranitsaris, George, Maroun, Jean, Shah, Amil

Journal:

Canadian journal of gastroenterology

Year:

2005

File:

PDF, 1.26 MB

2005

29

Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer

Leung, P. P., Tannock, I. F., Oza, A. M., Puodziunas, A., Dranitsaris, G.

Journal:

Journal of Clinical Oncology

Year:

1999

Language:

english

File:

PDF, 127 KB

english, 1999

30

P285 A clinical comparison of letrozole or anastrozole for the treatment of hormone-positive breast cancer using indirect statistical techniques

G. Dranitsaris, S. Kaura

Journal:

Year:

2011

Language:

english

File:

PDF, 38 KB

english, 2011

31

PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) Analysis

Kaura, S., Dranitsaris, G.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 53 KB

english, 2012

32

Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada

Abbott, R., Edwards, S., Whelan, M., Edwards, J., Dranitsaris, G.

Journal:

Journal of Oncology Pharmacy Practice

Year:

2014

Language:

english

File:

PDF, 127 KB

english, 2014

33

Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

Clemons, M. J., Dranitsaris, G., Ooi, W. S., Yogendran, G., Sukovic, T., Wong, B. Y.L., Verma, S., Pritchard, K. I., Trudeau, M., Cole, D. E.C.

Journal:

Journal of Clinical Oncology

Year:

2006

Language:

english

File:

PDF, 165 KB

english, 2006

34

Abraxane(R) versus Taxol(R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective

Dranitsaris, G., Yu, B., Wang, L., Sun, W., Zhou, Y., King, J., Kaura, S., Zhang, A., Yuan, P.

Journal:

Journal of Oncology Pharmacy Practice

Year:

2014

Language:

english

File:

PDF, 141 KB

english, 2014

35

A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer

Jacobs, C., Kuchuk, I., Bouganim, N., Smith, S., Mazzarello, S., Vandermeer, L., Dranitsaris, G., Dent, S., Gertler, S., Verma, S., Song, X., Simos, S., Cella, D., Clemons, M.

Journal:

Breast Cancer Research and Treatment

Year:

2016

Language:

english

File:

PDF, 539 KB

english, 2016

36

Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs

Dranitsaris, George, Zhu, Xiaofu, Adunlin, Georges, Vincent, Mark D

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2018

Language:

english

File:

PDF, 900 KB

english, 2018

37

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Eitan Amir, Christine E. Simmons, Orit C. Freedman, George Dranitsaris, David E. C. Cole, Reinhold Vieth, Wei S. Ooi, Mark Clemons

Journal:

Year:

2010

Language:

english

File:

PDF, 208 KB

english, 2010

38

Baseline radiological staging in early breast cancer: A comparison of practice guideline recommendations with actual clinical practice

M. Clemons, F. Wright, E. McWhirter, G. Dranitsaris, C. Holloway, F. Charbonneau, M. Trudeau, A. Smith, G. Yogendran, A. Mehlenbacher

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

39

How much benefit is needed to continue aromatase inhibitors (Als) beyond 5 years – A patient and physician survey

S. Gandhi, K. Towns, S. Allegro, N. Merchant, R. Tseng, G. Dranitsaris, T. Petrella, R. Dent, S. Verma

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

40

A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)

Dranitsaris, G., Kaura, S.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 58 KB

english, 2013

41

Meta-Regression Analysis to Indirectly Compare Prophylaxis With Dalteparin or Enoxaparin in Patients at High Risk for Venous Thromboembolic Events

Dranitsaris, G., Jelincic, V., Choe, Y.

Journal:

Clinical and Applied Thrombosis/Hemostasis

Year:

2012

Language:

english

File:

PDF, 281 KB

english, 2012

42

Advances in Cancer Therapeutics and Patient Access to New Drugs

George Dranitsaris,Ilse Truter,Martie S. Lubbe,Eitan Amir…

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 140 KB

english, 2011

43

Lenalidomide versus bortezomib: an indirect comparison

Dranitsaris, George, Kaura, Satyin

Journal:

International Journal of Hematologic Oncology

Year:

2014

Language:

english

File:

PDF, 1.37 MB

english, 2014

44

Cost Utility Analysis of First-Line Hormonal Therapy in Advanced Breast Cancer

Dranitsaris, George, Verma, Shailendra, Trudeau, Maureen

Journal:

American Journal of Clinical Oncology

Year:

2003

Language:

english

File:

PDF, 408 KB

english, 2003

45

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis

George Dranitsaris, Haytham Khoury

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 217 KB

english, 2011

46

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

O. C. Freedman, E. Amir, W. Hanna, H. Kahn, F. O’Malley, G. Dranitsaris, D. E. C. Cole, S. Verma, E. Folkerd, M. Dowsett, M. Clemons

Journal:

Breast Cancer Research and Treatment

Year:

2010

Language:

english

File:

PDF, 257 KB

english, 2010

47

The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia

Eleftheria Hatzimichael, Aggeliki Dasoula, Reshma Shah, Nelofer Syed, Alexandra Papoudou-Bai, Helen M. Coley, George Dranitsaris, Konstantinos L. Bourantas, Justin Stebbing, Tim Crook

Journal:

European Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 127 KB

english, 2010

48

Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?

Dranitsaris, George, Clemons, Mark

Journal:

Supportive Care in Cancer

Year:

2014

Language:

english

File:

PDF, 76 KB

english, 2014

49

The Economic Value of a New Insulin Preparation, Humalog® Mix 25™

George Dranitsaris,Christopher J. Longo,Loren D. Grossman

Journal:

PharmacoEconomics

Year:

2000

Language:

english

File:

PDF, 188 KB

english, 2000

50

The role of urinary N-telopeptides in evaluating the palliative benefit of bisphosphonates in metastatic breast cancer

Broom, Reuben, Simmons, Christine, Clemons, Mark, Cole, David, Dranitsaris, George

Journal:

Progress in Palliative Care

Year:

2007

Language:

english

File:

PDF, 210 KB

english, 2007

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски